2021-12156. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
-
Start Preamble
AGENCY:
Food and Drug Administration, Health and Human Services (HHS).
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Start SignatureTable 1—List of Information Collections Approved by OMB
Title of collection OMB control number Date approval expires FDA recall regulations 0910-0249 5/31/2024 Premarket Notification for a New Dietary Ingredient 0910-0330 5/31/2024 Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring 0910-0409 5/31/2024 Formal Dispute Resolution; Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice 0910-0563 5/31/2024 Substances Prohibited From Use in Animal Food or Feed 0910-0627 5/31/2024 Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments 0910-0782 5/31/2024 Food Allergen Labeling and Reporting 0910-0792 5/31/2024 Study of Multiple Indications in Direct-to-Consumer Television Advertisements 0910-0897 5/31/2024 Dated: June 4, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-12156 Filed 6-9-21; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 06/10/2021
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2021-12156
- Pages:
- 30952-30952 (1 pages)
- Docket Numbers:
- Docket Nos. FDA-2014-N-1031, FDA-2013-N-0878, FDA-2014-N-0998, FDA-2014-N-1076, FDA-2013-N-0520, FDA-2017-N-6397, FDA-2014-N-1030, and FDA-2020-N-1228
- PDF File:
- 2021-12156.pdf
- Supporting Documents:
- » Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
- » Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
- » Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
- » Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
- » Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
- » Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
- » Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
- » Agency Information Collection Activities Submission for Office of Management and Budget Review Comment Request Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
- » Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring